In keeping with these concepts, recent reports have also shown that CD19+ B cells from both RA patients and healthy individuals are capable of producing IL-17A [39], a pleiotropic cytokine involved in multiple aspects of immune function, inflammation, and bone damage. The gene discussed is IL17A; the disease is rheumatoid arthritis.